APA (7th ed.) Citation

A, B., K, O., JL, J., PS, E., M, K., LA, B., . . . C, L. (2011). Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: A multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002). Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 17(4), 558. https://doi.org/10.1016/j.bbmt.2010.07.015

Chicago Style (17th ed.) Citation

A, Bashey, et al. "Reduced-intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Patients with Hematologic Malignancies Who Relapse Following Autologous Transplantation: A Multi-institutional Prospective Study from the Cancer and Leukemia Group B (CALGB Trial 100002)." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 17, no. 4 (2011): 558. https://doi.org/10.1016/j.bbmt.2010.07.015.

MLA (9th ed.) Citation

A, Bashey, et al. "Reduced-intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Patients with Hematologic Malignancies Who Relapse Following Autologous Transplantation: A Multi-institutional Prospective Study from the Cancer and Leukemia Group B (CALGB Trial 100002)." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, vol. 17, no. 4, 2011, p. 558, https://doi.org/10.1016/j.bbmt.2010.07.015.